Press Releases

Sep 8, 2026

Derek Hwang

Press Releases

Monte Rosa Therapeutics Announces Milestone Achievement Associated with Initiation of Phase 2 Clinical Study for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)

Monte Rosa Therapeutics announced that its collaborator Novartis has started a Phase 2 clinical trial for the investigational molecular glue degrader MRT-6160 (DDY391) targeting VAV1 in patients with Sjögren’s disease. Under their global exclusive license agreement, Monte Rosa will receive a $50 million milestone payment upon the first patient visi…

GLUE

Sep 8, 2026

Ajmal Hussain

Press Releases

Tonix Pharmaceuticals Promotes Thomas Englese, MBA, to Chief Commercial Officer

Tonix Pharmaceuticals Holding Corp. announced the promotion of Thomas Englese to Chief Commercial Officer. Mr. Englese will lead sales, marketing, and commercial operations for TONMYA, a first-in-class treatment for fibromyalgia, and other acute migraine products. The company emphasizes its strong launch progress and aims to expand access and incre…

TNXP

Sep 8, 2026

Marcus Reed

Press Releases

Del Taco Celebrates #1 Fast Food Honors With Free Tacos in Port St. Lucie

Del Taco, recognized as the #1 Best Fast Food Restaurant by USA TODAY's 10Best Reader's Choice Awards for 2026, is hosting a four-day promotional giveaway of free tacos at its Port St. Lucie location to thank customers and boost brand engagement. The celebration highlights Del Taco's commitment to quality ingredients and plans to introduce new menu…

TACO

Sep 8, 2026

Leila Farooq

Press Releases

Vor Completes Enrollment of Global Phase 3 UPSTREAM MG Trial and Expands Telitacicept Global Franchise into Ocular Myasthenia Gravis

Vor Bio announced the completion of enrollment in its global Phase 3 UPSTREAM MG trial evaluating telitacicept for generalized myasthenia gravis with topline results expected in the first half of 2027. The company also plans to begin a new Phase 3 trial for ocular myasthenia gravis in the same timeframe, expanding telitacicept's development across …

VOR

Sep 8, 2026

Jordan Park

Press Releases

Adlai Nortye Announces First Patient Dosed in Australia and U.S. FDA IND Clearance for AN4035, a First-in-Class Pan-RAS(ON) Inhibitor-Based ADC

Adlai Nortye Group Ltd. has dosed the first patient in Australia and received U.S. FDA clearance to begin a global Phase I clinical trial of AN4035, a first-in-class CEACAM5-targeting antibody-drug conjugate armed with a pan-RAS(ON) inhibitor designed for tumor-selective delivery. The trial will evaluate AN4035's safety, pharmacokinetics, and preli…

ANL

Sep 8, 2026

Priya Menon

Press Releases

Rigetti Signs Definitive Agreement for $100M with U.S. Government to Accelerate R&D for Superconducting Quantum Computing

Rigetti Computing announced a definitive agreement with the U.S. Department of Commerce for $100 million in funding under the CHIPS Act to accelerate research and development in superconducting quantum computing. The funding will support three key R&D projects focused on scaling quantum computers and advancing Rigetti's roadmap to commercial utilit…

RGTI

Sep 8, 2026

Derek Hwang

Press Releases

Lightbridge Letter to Shareholders Outlines Expedited Pathway to Bring Lightbridge Fuel™ to Commercial Reactors

Lightbridge Corporation announced its selection for the U.S. Department of Energy's Launch Pad INL Program, enabling an expedited two-pronged strategy to commercialize its advanced Lightbridge Fuel™. The Special HALEU Extrusion Demonstration (SHED) facility at Idaho National Laboratory will produce Lead Test Assemblies under DOE authorization, acce…

LTBR

Sep 8, 2026

Leila Farooq

Press Releases

Kura Oncology Appoints Jennifer Fulk as Chief Financial Officer

Kura Oncology has appointed Jennifer Fulk as Chief Financial Officer, bringing over 20 years of extensive biopharmaceutical finance experience. Ms. Fulk’s expertise spans commercial operations, R&D portfolio management, investor relations, and capital allocation. This leadership addition is expected to support Kura's commercial expansion of KOMZIFT…

KURA

Sep 8, 2026

Leila Farooq

Press Releases

ABM Reports Fiscal Third Quarter 2026 Results

ABM Industries Incorporated announced strong fiscal third quarter 2026 results with record quarterly revenue of $2.3 billion, a 4.2% increase year-over-year, driven by organic growth and acquisitions, notably in Manufacturing & Distribution and Aviation sectors. The company achieved a 19% increase in net income and adjusted net income, improved adj…

ABM

Sep 8, 2026

Caleb Monroe

Press Releases

Pharvaris Announces Positive Topline Data from CHAPTER-3 Pivotal Study of Deucrictibant XR for Prophylaxis of HAE Attacks

Pharvaris announced positive topline results from its CHAPTER-3 pivotal Phase 3 trial demonstrating that deucrictibant extended-release (XR) tablet significantly reduces hereditary angioedema (HAE) attacks by 83% compared to placebo. The treatment was well tolerated, met all primary and secondary efficacy endpoints, and provides early and sustained…

PHVS

Sep 8, 2026

Hana Yamamoto

Press Releases

Bullish releases August 2026 monthly metrics

Bullish, a NYSE-listed global digital asset platform, published its unaudited monthly trading metrics for August 2026 including trading volumes, average trading spreads, and volatility data for Bitcoin and Ethereum. The company also reiterated its comprehensive digital asset infrastructure services and provided context on metrics definitions and da…

BLSH

Sep 8, 2026

Marcus Reed

Press Releases

Bluejay Diagnostics and Lovell Government Services Announce Partnership to Expand Access to U.S. Federal Healthcare Markets

Bluejay Diagnostics announced a strategic partnership with Lovell Government Services to establish a federal market access and procurement infrastructure, facilitating the commercial introduction of Bluejay's Symphony near-patient diagnostic platform into large U.S. federal healthcare systems such as the VA, DoD, MHS, and IHS following FDA clearanc…

BJDX

Sep 8, 2026

Maya Rios

Press Releases

Nova Minerals’ Marches towards Antimony Production with Arrival of Processing & Refining Equipment in Alaska

Nova Minerals Corp has received approximately 500 tons of equipment at Port MacKenzie, Alaska, enabling construction of a planned antimony processing and refining facility. This milestone supports the company's goal to establish a secure, fully integrated domestic antimony supply chain, funded by a $43.4 million US Department of War award. Producti…

NVA

Sep 8, 2026

Ajmal Hussain

Press Releases

FTC Solar to Participate in Upcoming Investor Events

FTC Solar, Inc., a leading provider of solar tracker systems and related services, announced that its management team will attend upcoming investor events including the H.C. Wainwright Global Investment Conference and the TD Cowen Energy Conference. These meetings aim to foster investor relations and provide updates on the company's performance and…

FTCI

Sep 8, 2026

Hana Yamamoto

Press Releases

Belite Bio Announces Submission of New Drug Application to the Ministry of Health, Labour, and Welfare in Japan under the Sakigake Designation System for Tinlarebant for the Treatment of Stargardt Disease Type 1

Belite Bio submitted a New Drug Application for tinlarebant to Japan's Ministry of Health under the expedited Sakigake designation for Stargardt disease type 1, a rare inherited retinal disorder. The drug is also under Priority Review by the U.S. FDA with a target action date in early 2027. If approved, tinlarebant would be the first therapy availa…

BLTE

Sep 8, 2026

Avery Klein

Press Releases

Roivant Announces Positive Results from PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) and Unveils Ongoing Phase 3 PHrontier Study

Roivant Sciences announced highly positive Phase 2 trial results for mosliciguat, showing the largest-ever reduction in pulmonary vascular resistance in a randomized controlled pulmonary hypertension trial. Mosliciguat demonstrated significant improvements in six-minute walk distance and cardiac biomarker levels, alongside a favorable safety profil…

ROIV

Sep 8, 2026

Maya Rios

Press Releases

MediciNova to Participate in Two Investor Conferences in September

MediciNova, a clinical-stage biopharmaceutical company listed on NASDAQ (MNOV), announced participation in the H.C. Wainwright and ROTH Capital healthcare conferences in September. Management will discuss progress on their late-stage pipeline, including upcoming topline readouts from Phase 2 and Phase 3 studies involving MN-001 and MN-166 compounds…

MNOV

Sep 8, 2026

Caleb Monroe

Press Releases

AsiaStrategy Expands Bitcoin-Backed Pledging Business with New Institutional Credit Facility

AsiaStrategy has entered into a significant Bitcoin-collateralised credit facility with a leading institutional partner in Asia, adding recurring revenue to its pledging business and enhancing its digital asset treasury operations. The company plans to grow this lending business, explore new collateral types and lending structures, and pursue acqui…

SORA

Sep 8, 2026

Marcus Reed

Press Releases

Smackover Lithium Announces Positive Preliminary Economic Assessment for the Franklin Project, Its First Lithium Project in East Texas

Smackover Lithium, a partnership between Standard Lithium Ltd. (NYSE American: SLI) and Equinor, released a positive Preliminary Economic Assessment (PEA) for the Franklin lithium brine project in East Texas. The PEA highlights impressive economics with an after-tax NPV8 of $5.0 billion, IRR of 24%, and annual production capacity up to 70,000 tonne…

SLI

Sep 8, 2026

Avery Klein

Press Releases

Scripps Howard Fund marks 10 years of ‘If You Give a Child a Book …’ campaign with two-day donation match

The E.W. Scripps Company’s philanthropic arm, the Scripps Howard Fund, is marking the 10th anniversary of its 'If You Give a Child a Book …' campaign by doubling donations up to $200,000 over two days to support free book distribution to children in low-income U.S. schools. The initiative aims to foster childhood literacy by providing students with…

SSP

Sep 8, 2026

Sofia Navarro

Press Releases

RadNet, Inc. to Present at the Jefferies Healthcare Services and Technology Conference on September 15, 2026

RadNet, Inc., a leading US provider of outpatient diagnostic imaging services and related technology solutions, announced that its Executive Vice President and Chief Strategy Officer, Dr. Greg Sorensen, will present at the Jefferies Healthcare Services Conference on September 15, 2026. The presentation will be webcast live and archived for later vi…

RDNT

Sep 8, 2026

Sofia Navarro

Press Releases

AIR Announces Participation in Barclays Global Consumer Conference

AIR Global PLC, a Dubai-headquartered leader in advanced flavored inhalation technologies, announced CEO Stuart Brazier and CFO Bassem Lotfy will participate in a fireside chat at the Barclays Global Consumer Conference. The company highlighted its portfolio of nicotine and social inhalation brands and its focus on innovation and scientific researc…

AIIR

Sep 8, 2026

Ajmal Hussain

Press Releases

Beam Therapeutics Presents Updated Clinical Data from the Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at the European Respiratory Society (ERS) Congress 2026

Beam Therapeutics announced updated positive clinical results from its Phase 1/2 trial of BEAM-302, a liver-targeted base editing therapy for Alpha-1 Antitrypsin Deficiency (AATD). Data show that a single dose leads to durable increases in functional alpha-1 antitrypsin protein, reduction of mutant protein, and improved biomarkers associated with l…

BEAM

Sep 8, 2026

Priya Menon

Press Releases

Lithia & Driveway (LAD) Continues Strategic Network Expansion in Texas with Rockwall Hyundai Acquisition and Provides Share Repurchase Update

Lithia & Driveway (NYSE: LAD) has acquired Rockwall Hyundai in Texas, adding approximately $75 million in annualized revenue and strengthening its presence in the Dallas-Fort Worth market. The acquisition increases year-to-date expected annualized revenue acquired to $915 million. Additionally, the company updated its share repurchase program, havi…

LAD

Sep 8, 2026

Hana Yamamoto

Press Releases

Frank D. “Trey” Whitworth, Former Director of the NGA, Appointed as President of Satellogic

Satellogic, a NASDAQ-listed company specializing in Persistent Global Intelligence infrastructure, has appointed Vice Admiral (Ret.) Frank D. "Trey" Whitworth as President. Whitworth brings extensive leadership experience from his 36-year career in U.S. defense and intelligence agencies, including as NGA Director. His role will focus on integrating…

SATL